View of Incretin therapy for type 2 diabetes: GLP-1 receptor agonists and DPP-4 inhibitors

Return to Article Details Incretin therapy for type 2 diabetes: GLP-1 receptor agonists and DPP-4 inhibitors Download Download PDF